Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How effective are quadruple therapies as first-line H. pylori eradication therapies?

Nature Clinical Practice Gastroenterology & Hepatology volume 2, pages 174–175 (2005)Cite this article

boxed-textFischbach LA et al. (2004) Meta-analysis: the efficacy, adverse events, and adherence related to firstline anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 20: 1071–1082

Quadruple therapy should be used as a first-line treatment for H. pylori infection

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Borody TJ et al. (1987) Symptoms improve after the eradication of gastric Campylobacter pyloridis. Med J Aust 148: 450–451

    Google Scholar 

  2. de Boer W et al. (1995) Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 345: 817–820

    Article  CAS  Google Scholar 

  3. Malfertheiner P et al. (2002) Current concepts in the management of Helicobacter pylori infection—the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16: 167–180

    Article  CAS  Google Scholar 

  4. Gene E et al. (2003) Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther 17: 1137–1143

    Article  CAS  Google Scholar 

  5. Borody TJ (2000) Quadruple should be first-line therapy for Helicobacter pylori infection. In Helicobacter pylori: Basic Mechanisms to Clinical Cure, 629–633 Boston: Kluwer Academic Publishers

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Director of the Centre for Digestive Diseases, Sydney, Australia

    Thomas J Borody

Authors
  1. Thomas J Borody
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas J Borody.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borody, T. How effective are quadruple therapies as first-line H. pylori eradication therapies?. Nat Rev Gastroenterol Hepatol 2, 174–175 (2005). https://doi.org/10.1038/ncpgasthep0137

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0137

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing